Rheumatoid Arthritis Clinical Trials in Houston

Showing 2341-2360 of 3,412 trials

Stem Cell Transplantation for Patients With Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning With CAMPATH 1H

NCT00048399

To assess the safety, feasibility, and rate of donor engraftment for patients with primary or secondary engraftment failure after treatment with fludarabine and CAMPATH 1H used as a preparative regimen for HLA-identical sibling blood stem cell transplantation (SCT). To assess the safety, feasibility, and rate of donor engraftment for patients with primary or secondary engraftment failure after treatment with fludarabine and CAMPATH 1H as a preparative regimen for matched unrelated or single antigen mismatched family donor marrow transplantation.

Graft Failure

Baylor College of Medicine40 participantsStarted Dec 2000

Houston, Texas, United States • Houston, Texas, United States

COMPLETEDPhase 1< 1 mile

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma

NCT02567656

The purpose of this study is to evaluate the safety, PK and efficacy of RP6530, a dual PI3K delta/gamma inhibitor in patients with relapsed and refractory T-cell Lymphoma.

Lymphoma, T-Cell, PeripheralLymphoma, T-Cell, Cutaneous

Rhizen Pharmaceuticals SA58 participantsStarted Sep 2015

Duarte, California, United States • Orange, California, United States • Aurora, Colorado, United States +5 more locations

COMPLETEDNA< 1 mile

Clinical Study Evaluating the Performance of HEMOBLAST Bellows Compared to FLOSEAL Hemostatic Matrix in Cardiothoracic Operations

NCT03725098

The purpose of this study is to evaluate the performance of HEMOBLAST™ compared to FLOSEAL in cardiothoracic operations.

Cardiothoracic Surgery

Biom'Up France SAS105 participantsStarted Mar 2019

Los Angeles, California, United States • Honolulu, Hawaii, United States • New Orleans, Louisiana, United States +1 more locations

Stem Cell Transplantation for Patients With Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning With CAMPATH 1H

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma

Clinical Study Evaluating the Performance of HEMOBLAST Bellows Compared to FLOSEAL Hemostatic Matrix in Cardiothoracic Operations

Rheumatoid Arthritis Trials in Other Cities

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism

Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis

Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degeneration

An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis

Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry

EverFlex Post Approval Study

A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib

MaxAn Post Market Surveillance Validation

Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade

Farber Disease Natural History Study

Other Conditions in Houston